Improving care for people with opioid use disorder using data science
Evaluating and Optimizing Care for Opioid Use Disorder using a Structured Data-Science Approach
This study is looking at how to improve treatment for people with opioid use disorder who also have HIV, by figuring out what helps them stay engaged in their care and how well different medications work, so that patients can get better support and have a smoother recovery journey.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10770542 on NIH RePORTER |
What this research studies
This research investigates how to enhance the treatment and retention of patients with opioid use disorder (OUD), particularly those also living with HIV. By analyzing data from the Veterans Health Administration, the study aims to identify factors that influence patient engagement in treatment and the effectiveness of medications like methadone, buprenorphine, and naltrexone. The approach includes examining the entire care process, from diagnosis to recovery, to find ways to improve patient outcomes and reduce dropout rates. Patients may benefit from insights that lead to better treatment strategies and support systems.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with opioid use disorder, especially those who are also living with HIV.
Not a fit: Patients who do not have opioid use disorder or those who are not engaged in treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment retention and outcomes for patients with opioid use disorder.
How similar studies have performed: Previous research has shown that data-driven approaches can effectively improve treatment outcomes for substance use disorders, indicating potential success for this study.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Lu, Haidong — Yale University
- Study coordinator: Lu, Haidong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.